Biggest News Aggregation in the World
📰 Csl Behring News

Page 4 - Csl Behring News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Csl Behring. Real-time updates on events, politics, business and more.

New Meta-Analysis of Patients with Acute Coronary Syndrome Shows Nearly Half of Recurrent Major Adverse Cardiovascular Events at One Year Occur Within the First 90 Days

/PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced the results of a new meta-analysis of seven interventional Phase 3 clinical trials...
Larry Deckelbaum C Michael Gibson Beth Israel Deaconess Medical Center American College Of Cardiology Circulation Research American College

Protein Therapeutics Market Overview; Size, Trends, Demand, Major Players, Challenges and Opportunities

Protein Therapeutics Market Overview; Size, Trends, Demand, Major Players, Challenges and Opportunities - IMARC Group iCrowd Newswire According to the recent report by IMARC Group, titled " Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025", the global protein therapeutics market grew at a CAGR of around 7% during 2014-2019. Looking forward, IMARC Group expects the global market to continue its moderate growth by 2025. Protein therapeut...
United States Europe Africa Asia Pacific Eli Lilly Csl Behring Roche Ag Holding

Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) Label Update Provides New Dosing Guidelines for Physicians, Allowing for Greater Flexibility in Treating CIDP Patients

Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) Label Update Provides New Dosing Guidelines for Physicians, Allowing for Greater Flexibility in Treating CIDP Patients The label update is based on open label extension data from the landmark PATH (Polyneuropathy And Treatment with Hizentra) study News provided by Share this article Share this article KING OF PRUSSIA, Pa., April 29, 2021 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the U.S. Food and...
Arie Katz Demyelinating Polyneuropathy Bernadine Koziara Drug Administration Behring Pharmacovigilance Department Immune Globulin Subcutaneous

CoVIg-19 Plasma Alliance Announces Topline Results from NIH-Sponsored Clinical Trial of Investigational COVID-19 Hyperimmune Globulin Medicine

CoVIg-19 Plasma Alliance Saturday, April 3, 2021 2:00PM IST (8:30AM GMT)   Osaka, Japan & King of Prussia, Pa., United States:    Phase 3 Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC) Clinical Trial Sponsored and Funded by the National Institute of Allergy and Infectious Diseases (NIAID), Part of the National Institutes of Health (NIH), Did Not Meet Its Endpoints to Show Efficacy in Adults Hospitalized With COVID-1...
United States Julie Kim Plasma Alliance Head Of Research National Institutes Of Health National Institute Of Allergy

Global HAE Therapies Market to 2025 - by Manufacturers, Regions, Technology, and Application

Global HAE Therapies Market to 2025 - by Manufacturers, Regions, Technology, and Application December 10, 2020 10:28 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.coms offering. This report describes the global market size of HAE Therapies from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For the geography segment, regio...
United States United Kingdom South Africa South Korea Asia Pacific Laura Wood

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science